These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31107966)

  • 1. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Chong J; Cates CJ
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN; Cates CJ
    Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN
    Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A; Poole P
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001287. PubMed ID: 16855965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
    Ni H; Aye SZ; Naing C
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2003; (2):CD001287. PubMed ID: 12804402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Normansell R; Maisey S; Poole P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D for the management of chronic obstructive pulmonary disease.
    Williamson A; Martineau AR; Jolliffe D; Sheikh A; Janssens W; Sluyter J; Rafiq R; de Jongh R; Griffiths CJ
    Cochrane Database Syst Rev; 2024 Sep; 9(9):CD013284. PubMed ID: 39329240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.